Elizabeth Patrick
First SEC filing: Aug. 30, 2024 · Latest: Aug. 30, 2024
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 11, 2026 | COHR | A | 279 | · | · | 5,382 Direct | +5.47% | Acquired | (price as of 2026-10-02) |
| Aug. 28, 2025 | COHR | A | 2,272 | · | · | 5,103 Direct | +80.25% | Acquired | (price as of 2026-10-02) |
| Nov. 13, 2024 | COHR | S | 2,000 | $104.00 | $208,000 | 6,373 Direct | -23.89% | Disposed | 224.1% (price as of 2026-10-02) |
| Nov. 13, 2024 | COHR | S | 3,542 | $105.00 | $371,910 | 2,831 Direct | -55.58% | Disposed | 221.0% (price as of 2026-10-02) |
| Aug. 29, 2024 | COHR | A | 2,831 | · | · | 8,373 Direct | +51.08% | Acquired | (price as of 2026-10-02) |
| Nov. 28, 2023 | COHR | A | 5,542 | · | · | 5,542 Direct | · | Acquired | (price as of 2026-10-02) |
| April 8, 2022 | DBD | F | 1,642 | $5.39 | $8,850 | 155,351 Direct | -1.05% | Disposed | 1083.1% (price as of 2026-10-02) |
| March 8, 2022 | DBD | A | 117,846 | · | · | 156,993 Direct | +301.03% | Acquired | (price as of 2026-10-02) |
| Feb. 5, 2022 | DBD | F | 2,158 | $8.25 | $17,804 | 39,147 Direct | -5.22% | Disposed | 673.0% (price as of 2026-10-02) |
| Jan. 30, 2022 | DBD | F | 1,875 | $8.80 | $16,500 | 41,305 Direct | -4.34% | Disposed | 624.7% (price as of 2026-10-02) |
| April 8, 2021 | DBD | F | 2,461 | $13.19 | $32,461 | 43,180 Direct | -5.39% | Disposed | 383.5% (price as of 2026-10-02) |
| Feb. 5, 2021 | DBD | A | 18,465 | · | · | 45,641 Direct | +67.95% | Acquired | (price as of 2026-10-02) |
| Jan. 30, 2021 | DBD | F | 2,670 | $13.66 | $36,472 | 27,176 Direct | -8.95% | Disposed | 366.8% (price as of 2026-10-02) |
| April 8, 2020 | DBD | F | 2,406 | $4.42 | $10,635 | 29,846 Direct | -7.46% | Disposed | 1342.8% (price as of 2026-10-02) |
| Jan. 30, 2020 | DBD | A | 7,087 | · | · | 7,087 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 30, 2020 | DBD | A | 15,888 | · | · | 32,252 Direct | +97.09% | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 30, 2020 | DBD | Non-Qualified Stock Option [F3] | Common Shares | $11.96 | Jan. 30, 2030 | 7,087 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2022 | · | · | · | · | · | · | $1,579,097 | $3,199,953 |
| 2021 | · | · | · | · | · | · | · | · |
| 2020 | · | · | · | · | · | · | · | · |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.